Previous 10 | Next 10 |
LEXINGTON, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced it will unveil new data at industry conferences this month to showcase results and implications of the use of its rapid diagno...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As the Covid-19 pandemic continues to develop and shift, the need for rapid detection of viruses before symptoms arise has become increasingly clear. T2 Biosystems (NASDAQ: TTOO ), an emerging leader in the field of c...
LEXINGTON, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel—a molecular diagnostic test that detects SARS-CoV-2, the virus responsibl...
LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today plans to consolidate its existing facilities and expand into a newly leased facility in Billerica, Massachusetts. The Com...
LEXINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced efforts in recognition of Sepis Awareness Month to educate on the importance of rapid diagnostic technologies at a time when s...
Spectrum Pharmaceuticals SPPI -35% after FDA declines to approve ROLONTIS Dicerna Pharmaceuticals DRNA -28% slide despite pivotal nedosiran study hitting primary endpoint Zynga ZNGA -16% on Q2 earnings release Chembio Diagnostics CEMI -13% on Q2 earning...
T2 Biosystems, Inc. (TTOO) Q2 2021 Earnings Conference Call August 05, 2021, 16:30 ET Company Participants Greg Chodaczek - Managing Director, Gilmartin Group John Sperzel - Chairman & CEO John Sprague - CFO Conference Call Participants Presentation Operator Greetings, and welcome to the ...
LEXINGTON, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the three months ended June 30, 2021. Recent Highlights Achieved second quarter 2021...
LEXINGTON, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming Canaccord Genuity 41st Annual Growth Conference. Management is scheduled to pre...
The healthcare industry is growing, with significant investments in research and development and technological transformation. Given the industry tailwinds, Wall Street analysts expect healthcare stocks T2 Biosystems (TTOO) and OpGen (OPGN), which are currently trading at less than $10, to do...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the first quarter 2024 and business updates after mar...
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financia...
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion ...